A phase I study of moxetumomab pasudotox in adults with relapsed or refractory B‐cell acute lymphoblastic leukaemia. (14th June 2017) - Short, Nicholas J.; Kantarjian, Hagop; Jabbour, Elias; Cortes, Jorge E.; Thomas, Deborah A.; Rytting, Michael E.; Daver, Naval; Alvarado, Yesid; Konopleva, Marina; Kebriaei, Partow; Wierda, William G.; DiNardo, Courtney D.; et al.